Atlas Trials

Evaluation of the Effectiveness of the Use of a Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the Pathogenetic Therapy of Metabolic-associated Fatty Liver Disease: a Prospective Cohort Study

Clinical trial NCT06078722 · UNKNOWN

Trial details

NCT number
NCT06078722
Sponsor
Kazakh Association of Internal Medicine Specialists
Status
UNKNOWN
Study type
OBSERVATIONAL
Metabolic-associated Fatty Liver Disease (MAFLD)
Start date
2023-02-08
Primary completion
2025-02-08
Enrollment
264

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.